Shares of DaVita Inc. (NYSE:DVA – Get Rating) have been assigned an average recommendation of “Hold” from the eight ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and two have given a buy recommendation to […]
DaVita Inc. (NYSE:DVA – Get Rating) has been given an average rating of “Hold” by the eight ratings firms that are presently covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1 year price target among […]
DaVita (NYSE:DVA – Get Rating) and Marpai (NASDAQ:MRAI – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends. Analyst Recommendations This is a summary of recent ratings and target prices […]
DaVita (NYSE:DVA – Get Rating) updated its FY22 earnings guidance on Thursday. The company provided EPS guidance of $7.50-8.50 for the period, compared to the consensus EPS estimate of $7.99. A number of analysts have commented on the company. Truist Financial reduced their target price on DaVita from $125.00 to $110.00 in a report on […]
Gulf International Bank UK Ltd lowered its position in shares of DaVita Inc. (NYSE:DVA – Get Rating) by 14.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,383 shares of the company’s stock after selling 2,213 shares during the period. Gulf […]